Labcorp

Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5% Outlines strategic growth priorities driven by a differentiated platform powered by science, technology and global scale Presents long-term value creation framework driven by sustainable growth, strong cash flow generation and disciplined capital deployment , /PRNewswire/ -- Labcorp (NYSE: LH),...

Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed.

Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery.

Labcorp Holdings Inc. at the Morgan Stanley 24th Annual Global Healthcare Conference

Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 15, at 11:30 a.m. ET.

10-year agreement reinforces Labcorp's role as primary diagnostics partner for the Military Health System BURLINGTON, N.C., Aug. 27, 2026 — Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced an agreement with the Defense Health Agency (DHA) to continue serving as the primary commercial clinical reference laboratory provider for the Military Health System.

Hepatitis D occurs only in people with hepatitis B and is associated with a higher risk of cirrhosis, liver cancer and other serious liver complications When ordered by a clinician, reflex testing automatically performs hepatitis D testing for patients who test positive for hepatitis B surface antigen (HBsAg) Supports earlier diagnosis as emerging hepatitis D treatment options increase the importance of timely detection BURLINGTON, N.C. (Aug.

Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settings Measures phosphorylated Tau 217 (pTau-217), an indicator of amyloid pathology and a hallmark of Alzheimer's disease Intended for individuals 55 and older with signs, symptoms or complaints of cognitive decline , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced...